All companies
Visit website
ALLERPOPS
OperatingAllerPops Corp
Founded 2016
Liberate millions from allergies
Post-money valuation ⓘ
$9.9M
As of Aug 2023 · from ALLERPOPS Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$419,635
Across 2 rounds since 2021
Latest share price
$1.10
ALLERPOPS Preferred Stock 2 offering price
Financials
FY2018–FY2021 · from SEC filings · hover any figure for its source$21K
−$163K
2018
$21K
−$163K
2019
$41K
−$137K
2020
$58K
−$353K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
Income statement
Revenue
$20,549
$20,549
$40,802
$58,156
Cost of goods sold
$4,035
$4,035
$8,327
$16,394
Gross margin
80%
80%
80%
72%
Net income
-$163,330
-$163,330
-$136,665
-$353,340
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$4,916
$4,916
$64,089
$26,616
Accounts receivable
$0
$0
$150
$300
Total assets
$84,579
$84,579
$204,095
$181,458
Short-term debt
$4,496
$4,496
$17,342
$19,360
Long-term debt
$0
$0
$199,131
$291,962
Total liabilities
$4,496
$4,496
$216,473
$311,322
Other
Headcount
—
1
—
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$7.8M
post-money
$9.9M
post-money
Allerpops Stock 1
ALLERPOPS Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $166.1K / $618KInvestors 193Post-money $9.9M
Raised $253.5K / $500KInvestors 295Post-money $7.8M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 6 annual reports (FY2020–FY2025)
295 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001839211Share price $1.10
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.